Urate-Lowering Treatments Compared for Gout

THURSDAY, July 7, 2022 -- For relatively young and healthy patients with gout caused by renal underexcretion of uric acid, low-dose benzbromarone (LDBen) has a greater urate-lowering effect than low-dose febuxostat (LDFeb), according to a study...

Source: Drugs.com - Pharma News - July 7, 2022 Category: Pharmaceuticals Source Type: news